RU2002114913A - A method for the treatment of secondary hypoestrogenism - Google Patents

A method for the treatment of secondary hypoestrogenism

Info

Publication number
RU2002114913A
RU2002114913A RU2002114913/14A RU2002114913A RU2002114913A RU 2002114913 A RU2002114913 A RU 2002114913A RU 2002114913/14 A RU2002114913/14 A RU 2002114913/14A RU 2002114913 A RU2002114913 A RU 2002114913A RU 2002114913 A RU2002114913 A RU 2002114913A
Authority
RU
Russia
Prior art keywords
hypoestrogenism
treatment
hypoestrogenia
daily
days
Prior art date
Application number
RU2002114913/14A
Other languages
Russian (ru)
Other versions
RU2232023C2 (en
Inventor
Алексей Михайлович Герасимов
Сергей Юрьевич Штрыголь
Любовь Валентиновна Посисеева
Original Assignee
ГУ Ивановский НИИ материнства и детства им. В.Н. Городкова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ГУ Ивановский НИИ материнства и детства им. В.Н. Городкова filed Critical ГУ Ивановский НИИ материнства и детства им. В.Н. Городкова
Priority to RU2002114913/14A priority Critical patent/RU2232023C2/en
Publication of RU2002114913A publication Critical patent/RU2002114913A/en
Application granted granted Critical
Publication of RU2232023C2 publication Critical patent/RU2232023C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

Способ лечения вторичной гипоэстрогении, отличающийся тем, что используется 25%-ный раствор сульфата магния по 10 мл внутримышечно, ежедневно, в течение 5 дней.A method of treating secondary hypoestrogenia, characterized in that a 25% solution of magnesium sulfate of 10 ml is used intramuscularly, daily, for 5 days.
RU2002114913/14A 2002-06-06 2002-06-06 Method for treating secondary hypoestrogeny RU2232023C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002114913/14A RU2232023C2 (en) 2002-06-06 2002-06-06 Method for treating secondary hypoestrogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002114913/14A RU2232023C2 (en) 2002-06-06 2002-06-06 Method for treating secondary hypoestrogeny

Publications (2)

Publication Number Publication Date
RU2002114913A true RU2002114913A (en) 2004-01-10
RU2232023C2 RU2232023C2 (en) 2004-07-10

Family

ID=33412525

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002114913/14A RU2232023C2 (en) 2002-06-06 2002-06-06 Method for treating secondary hypoestrogeny

Country Status (1)

Country Link
RU (1) RU2232023C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10857313B2 (en) 2014-07-01 2020-12-08 Aerami Therapeutics, Inc. Liquid nebulization systems and methods

Also Published As

Publication number Publication date
RU2232023C2 (en) 2004-07-10

Similar Documents

Publication Publication Date Title
GB0223038D0 (en) Therapeutic compounds
GB0225474D0 (en) Therapeutic agents
GB0225475D0 (en) Therapeutic agents
DE60218493D1 (en) SUBSTITUTED 7-AZA-Ä2.2.1ÜBICYCLOHEPTANE FOR THE TREATMENT OF DISEASES
GB0318447D0 (en) Therapeutic agents
ATE410430T1 (en) 2,3-DIHYDRO-6-NITROIMIDAZOÄ2,1-BUOXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS
JO2311B1 (en) Alkyne-aryl phosphodiesterase-4 inhibitors
SE9900100D0 (en) New compounds
MXPA05012323A (en) Cyclic sulfonamides for inhibition of gamma-secretase.
DE60319066D1 (en) 1,4-DISUBSTITUTED BENZO-CONDENSED CYCLOALKYL UREA COMPOUNDS FOR THE TREATMENT OF CYTOKIN-MEDIATED DISEASES
EP1769791A3 (en) Treatment of Alzheimer's disease with cell cycle inhibitors
BR0308904A (en) Method of treatment of gastroparesis and use of a glp-1 compound
ATE384699T1 (en) 2,6-QUINOLINYL AND 2,6-NAPHTHHYL DERIVATIVES AND USES THEREOF FOR TREATING VLA-4 RELATED DISEASES
WO2003106450A8 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
SE0301368D0 (en) Chemical compounds
ATE422498T1 (en) TETRAHYDRO-PYRAZINOÄ1,2-AÜINDOLE FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
DE59914712D1 (en) USE OF INHIBITORS OF THE KQT1 CHANNEL FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISEASES CAUSED BY HELMINTH AND ECOPOPARASITES
SE0200843D0 (en) Chemical compounds
SE0101082D0 (en) Novel use
DE50205466D1 (en) SUBSTITUTED 2,5-DIAMIDOINDOLE AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
MXPA04000446A (en) Substituted 4-aminocyclohexanols.
ATE344662T1 (en) AGENTS CONTAINING N-CHLORTAURINE AND THEIR USE FOR THE TREATMENT OF MUCOUS POLYPS
RU2002114913A (en) A method for the treatment of secondary hypoestrogenism
WO2003053352A3 (en) Therapeutic compounds for treating dyslipidemic conditions

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20040607